This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Nature Reviews - Cardiology
SEPTEMBER 16, 2024
Nature Reviews Cardiology, Published online: 17 September 2024; doi:10.1038/s41569-024-01070-6 The gut microbiota has emerged as a risk factor that affects thrombotic phenotypes in several cardiovascular diseases.
133 
DAIC
NOVEMBER 8, 2024
tim.hodson Fri, 11/08/2024 - 10:10 Medtronic recently announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions. Results from both analyses were released at the Vascular InterVentional Advances (VIVA) 2024 conference in Las Vegas. versus 21.1%, P =0.014).
52 
American Heart News - Stroke News
JANUARY 29, 2024
DALLAS, January 29, 2024 — A new scientific statement from the American Heart Association emphasizes the need to increase patients’ and physicians’ awareness of cerebral venous thrombosis (CVT) to improve the recognition of this condition and initiate.
133 
Cardiology Update
FEBRUARY 11, 2024
Bioprosthetic valve dysfunction (BVD) was categorized into structural valve deterioration (SVD), non-structural valve dysfunction (NSVD), clinical valve thrombosis, or endocarditis. No cases of clinical valve thrombosis were reported. European Heart Journal (2024) 00, 1–9. Severe SVD was defined by specific criteria.
124 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP227-AWP227, February 1, 2024. Introduction:Deep medullary vein(DMV) thrombosis is a rare cause of neurological damage noted in both term and preterm infants. The spectrum of parenchymal radiological findings in DMV thrombosis includes edema and hemorrhage of variable extent.
40 
DAIC
SEPTEMBER 10, 2024
tim.hodson Tue, 09/10/2024 - 13:34 Sept. Angiolillo, MD, PhD, FACC, FESC, FSCAI, Professor of Medicine, Chief, Division of Cardiology, Director, Thrombosis Research Center, University of Florida, College of Medicine-Jacksonville. 5,2024 - Prolocor, Inc.
52 
HCPLive
JANUARY 2, 2025
Bendapudi gave an overview of 2 studies presented at ASH 2024 from his Harvard lab.
59 59 
DAIC
MAY 15, 2024
Getty Images milla1cf Wed, 05/15/2024 - 19:10 May 15, 2024 — A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the heart— transcatheter aortic valve replacement (TAVR)—and surgical aortic valve replacement (SAVR).
105 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4142998-A4142998, November 12, 2024. Introduction:Subclinical leaflet thrombosis is an increasingly recognized complication in patients undergoing transcatheter aortic valve replacement (TAVR).
40 
Circulation
SEPTEMBER 15, 2024
Circulation, Volume 150, Issue 12 , Page 905-907, September 17, 2024.
45 
Cardiology Update
APRIL 9, 2024
The American College of Cardiology (ACC) held its 73 rd annual scientific session and expo April 6-8, 2024 in Atlanta, Georgia. The primary non-inferiority endpoint was MACCE (a composite of cardiac death, MI, ischaemic stroke, stent thrombosis, or target vessel revascularisation). April 6, 2024. April 7, 2024.
52 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATP180-ATP180, February 1, 2024. Background:Coronavirus disease 2019 (COVID-19) increases the risk of cerebral venous sinus thrombosis (CVST), and previous reports derived from small case series reported a high mortality in these patients, up to 40%.
40 
DAIC
MAY 31, 2024
milla1cf Fri, 05/31/2024 - 07:00 May 31, 2024 — In the United States there are over 8 million active athletes. Clinical Cases and Poster Presentations The following list provides a brief look at the clinical cases and posters to be presented during the ACC Care of the Athletic Heart 2024 conference.
111 
DAIC
JUNE 12, 2024
It enrolled 162 subjects at 30 centers with three patient populations – non-thrombotic iliac vein lesion (NIVL), post-thrombotic syndrome (PTS) and acute deep vein thrombosis (aDVT). Current and future burden of venous thrombosis: Not simply predictable. J Thromb Haemost 2014; 12: 1580–90. 2] Scheres LJJ, Lijfering WM, Cannegieter SC.
105 
Cardiometabolic Health Congress
AUGUST 23, 2024
The 2024 report from the Lancet Standing Commission on Dementia Prevention, Intervention, and Care brings promising developments for healthcare professionals and public health advocates. The Takeaway The 2024 Lancet Commission report is a call to action for healthcare providers and public health advocates. Michos, MD ; Pamela B.
52 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATMP62-ATMP62, February 1, 2024. Introduction:Seizures are a common initial manifestation of cerebral venous thrombosis (CVT).
40 
Stroke Journal
JANUARY 30, 2025
Introduction:The majority of patients with cerebral venous thrombosis (CVT) achieve functional independence (modified Rankin Score [mRS] 0-2), although many continue to experience residual symptoms that negatively impact quality of life. Stroke, Volume 56, Issue Suppl_1 , Page AWP143-AWP143, February 1, 2025.
40 Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWMP59-AWMP59, February 1, 2024. Background:Information on long-term care utilization patterns following the acute care period of cerebral venous thrombosis (CVT) is limited.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP260-AWP260, February 1, 2024. Background:Cerebral venous thrombosis (CVT) is associated with significant risk of death and disability.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATP7-ATP7, February 1, 2024. Our findings highlight the potential of conservative care for ruptured spinal artery aneurysms, with spontaneous thrombosis demonstrated on short-term follow-up angiograms. While morbidity and mortality seem low, limited data makes generalizations difficult.
40 
The American Journal of Cardiology
NOVEMBER 22, 2024
Publication date: Available online 22 November 2024 Source: The American Journal of Cardiology Author(s): Rahul Chaudhary, Matthew E. Harinstein
40 40 
The American Journal of Cardiology
OCTOBER 24, 2024
Publication date: Available online 23 October 2024 Source: The American Journal of Cardiology Author(s): Semih Kalkan, M.Ozan Gürsoy, Ahmet Güner, Semra Gürsoy, Macit Kalçık, Bilge Bilgen Geçkinli, Kenan Delil, Esra Arslan Ateş, Eylem Gokmeydan Erdogan, Sezin Canbek, Emrah Bayam, A.
40 40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATP267-ATP267, February 1, 2024. Introduction:Exposure to high altitude environment is a risk factor of cerebral venous thrombosis (CVT) probably due to the hypercoagulability.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP149-AWP149, February 1, 2024. Background:Direct oral anticoagulants (DOACs) are suitable for some patients with cerebral venous thrombosis (CVT). The optimal transition strategy from parenteral anticoagulation (PA) to DOAC is not known.
40 
DAIC
JANUARY 11, 2024
Imge courtesy of Won-Young Kim from Chung-Ang University milla1cf Thu, 01/11/2024 - 08:30 January 11, 2024 — Acute cardiovascular manifestations of COVID-19 , such as heart failure, thrombosis, and dysrhythmia, are associated with increased mortality.
103 
The American Journal of Cardiology
DECEMBER 3, 2024
Publication date: Available online 2 December 2024 Source: The American Journal of Cardiology Author(s): Xinhai Huang, Donglin Xie, Jie Huang, Ruijuan Li, Qiaowei Zheng, Xiumei Liu, Hengfen Dai, Xiangsheng Lin, Yuxin Liu, Jun Su, Xiaomin Dong, Yanxian Lan, Cuifang You, Shuzheng Jiang, Jinhua Zhang
Dr. Smith's ECG Blog
SEPTEMBER 18, 2024
5 We are aware that the current consensus is that the propensity for plaques to rupture is independent of plaque size; however, in our opinion, the hypothesis that small atherosclerotic plaques are the most likely to rupture, with resulting occlusive thrombosis, is unproven. These are typical findings at sites of plaque rupture.
121 
Stroke Journal
JANUARY 21, 2024
Stroke, Volume 55, Issue 2 , Page 311-323, February 1, 2024. The mechanisms by which ICAD causes stroke include plaque rupture with in situ thrombosis and occlusion or artery-to-artery embolization, hemodynamic injury, and branch occlusive disease.
74 
The American Journal of Cardiology
JULY 18, 2024
Publication date: Available online 17 July 2024 Source: The American Journal of Cardiology Author(s): Gani Bajraktari, Ibadete Bytyçi, Genc Abdyli, Pranvera Ibrahimi, Artan Bajraktari, Rona Karahoda, Shpend Elezi, Michael Y.
40 
Journal of Cardiovascular Pharmacology
AUGUST 1, 2024
Thrombosis continues to pose a significant challenge in cardiovascular and cerebrovascular diseases, contributing to severe health complications such as myocardial infarction, acute ischemic stroke, and venous thromboembolism. Copyright © 2024 Wolters Kluwer Health, Inc. In this paper, we comment the findings reported by Liu et al.
Circulation: Cardiovascular Interventions
MARCH 30, 2025
However, whether the addition of OCT to angiography to guide percutaneous coronary intervention (PCI) of complex lesions affects clinical outcomes is debated.Methods:A systematic search for randomized controlled trials (RCTs) was conducted using PubMed, Scopus, and Cochrane databases through September 2024.
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4145424-A4145424, November 12, 2024. The outcome was any 30-day event defined as death, stent thrombosis, major bleeding events, and composites of ischemic and bleeding events. 41% patients were treated with immediate dual therapy, and 59% were discharged on triple therapy.
40 
The American Journal of Cardiology
MARCH 7, 2024
Publication date: Available online 7 March 2024 Source: The American Journal of Cardiology Author(s): Federica Troisi, Pietro Guida, Nicola Vitulano, Federico Quadrini, Antonio Di Monaco, Giuseppe Patti, Massimo Grimaldi
Journal of Cardiovascular Pharmacology
APRIL 9, 2024
Clinical practice shows that a critical unmet need in the field of thrombosis prevention is the availability of anticoagulant therapy without bleeding risk. Clinical practice shows that a critical unmet need in the field of thrombosis prevention is the availability of anticoagulant therapy without bleeding risk.
40 
DAIC
OCTOBER 16, 2024
tim.hodson Wed, 10/16/2024 - 09:00 Oct. 16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial results in Circulation: Cardiovascular Interventions , a journal of The American Heart Association. Led by Dr. Pieter C.
52 
Stroke Journal
JANUARY 30, 2025
Direct oral anticoagulants (DOACs) are approved in many countries for the treatment and prevention of pediatric venous thrombosis but its use in pediatric arterial thrombosis is less established. Patients (0 to <18 years) treated at CCMC for acute AIS that received rivaroxaban between June 21, 2021-April 1, 2024 were reviewed.
40 Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page A134-A134, February 1, 2024. In severe OHSS, increases in capillary permeability can result in hemoconcentration and hypercoagulability leading to thrombotic events, including stroke and cerebral venous thrombosis.
40 
Journal of Cardiovascular Pharmacology
FEBRUARY 28, 2024
However, despite a heterogenous substrate underlying coronary thrombosis, treatment remains identical. However, despite a heterogenous substrate underlying coronary thrombosis, treatment remains identical. Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
40 Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4141755-A4141755, November 12, 2024. However, it subjects patients to lifelong warfarin therapy after MHVR, with the attendant risk of bleeding and thrombosis. Background:Mechanical heart valve replacement (MHVR) is an effective method for the treatment of severe heart valve disease.
40 
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4142117-A4142117, November 12, 2024. Introduction:The management of patients with Venous thromboembolism (VTE) receiving anticoagulant therapy is complicated by potential interactions with other medications, including antibiotics.
40 
The British Journal of Cardiology
MAY 14, 2024
The prospect of uncoupling the management of thrombosis from the bleeding risk inadvertently associated with current therapy inspired the development of agents directed towards this step in the coagulation process.
40 
Journal of Cardiovascular Pharmacology
SEPTEMBER 5, 2024
This review of the evidence for bivalirudin utilization in ECMO suggests favorable outcomes in circuit-related thrombosis, bleeding, and dosing reliability. This review of the evidence for bivalirudin utilization in ECMO suggests favorable outcomes in circuit-related thrombosis, bleeding, and dosing reliability. All rights reserved.
40 Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATP278-ATP278, February 1, 2024. The "PAIST Scale" of the thrombolysis patients included: Baseline NIHSS (5-15 = 11, ≥ 16 = 20), deep vein thrombosis (yes = 5), Neuron specific enolase (> 13 ng/ml = 3), and neutrophil percentage (> 70% = 5). mmol/l = 2), serum potassium (< 3.8
40 Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATMP117-ATMP117, February 1, 2024. In the present study, we determined the effect of SH and RH on stroke risk/thrombosis in female rats. Stroke is a serious complication of diabetes. Intensive treatment of diabetes increases the risk of recurrent hypoglycemia (RH).
40
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content